Screener
Vir Biotechnology, Inc. VIR Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Vir Biotechnology, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Vir Biotechnology, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 5:20 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053549
FAQ
- What is Vir Biotechnology, Inc.'s current ratio?
- Vir Biotechnology, Inc. (VIR) reported current ratio of 6× in Q2 2026.
- How has Vir Biotechnology, Inc.'s current ratio changed year-over-year?
- Vir Biotechnology, Inc.'s current ratio decreased by 13.8% year-over-year, from 7× to 6×.
- What is the long-term trend for Vir Biotechnology, Inc.'s current ratio?
- Over 5 years (2020 to 2025), Vir Biotechnology, Inc.'s current ratio has grown at a -6.6% compound annual growth rate (CAGR), from 7.8× to 5.5×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about Vir Biotechnology, Inc.'s current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude